Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.64 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.59 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.57 |
| ▸ | GLP1R | P43220 | 6/20 | 0.57 |
| ▸ | GIPR | P48546 | 6/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31332122 | 1.00 | CALCR (0.64) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL29533605 | 0.98 | CALCR (0.63) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL11651841 | 0.96 | CALCR (0.65) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL30439066 | 0.96 | CALCR (0.66) | CALCRCRHR1CRHR2OPRD1OPRM1 | |
| SCHEMBL11652679 | 0.95 | CALCR (0.65) | CALCRCRHR1CRHR2OPRD1OPRM1 | |
| SCHEMBL11651860 | 0.95 | CALCR (0.64) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL11650961 | 0.95 | OPRD1 (0.60) | CALCROPRD1OPRM1OPRK1GLP1R | |
| SCHEMBL11667794 | 0.95 | CALCR (0.64) | CALCRCRHR1CRHR2OPRD1OPRM1 | |
| SCHEMBL11665206 | 0.94 | CALCR (0.62) | CALCRNTSR1CRHR1CRHR2OPRD1 | |
| SCHEMBL11662077 | 0.94 | CALCR (0.67) | CALCRCRHR1CRHR2OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | claimed |
| EP-4637388-A1 | BIOACTIVE FOOD AND BEVERAGE COMPOSITIONS AND METHODS | FGS SCIENTIFIC PTY LTD (AU) | 2025-10-29 | — | — | EP | disclosed |
| US-20250243257-A1 | BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-07-31 | — | — | US | disclosed |
| CN-120079360-A | Oily sewage adsorbent and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-20250122309-A1 | Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same | OMEROS CORP (US) | 2025-04-17 | — | — | US | disclosed |
| US-20240400639-A1 | ENGINEERED EXTRACELLULAR RECEPTOR CONSTRUCTS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| US-12060591-B2 | Tau protease compositions and methods of use | OLIGOMERIX, INC. (US) | 2024-08-13 | — | — | US | disclosed |
| US-12043652-B2 | Engineered extracellular receptor constructs and uses thereof | TRUSTEES OF BOSTON UNIVERSITY | 2024-07-23 | — | — | US | disclosed |
| WO-2024134432-A1 | BIOACTIVE FOOD AND BEVERAGE COMPOSITIONS AND METHODS | FGS Scientific Pty Ltd (AU) | 2024-06-27 | — | — | WO | disclosed |
| CN-116940690-A | Comprising N γ -hydroxy-or N γ Polypeptide cyclization method of amino-L-asparagine | 南洋理工大学 | 2023-10-24 | — | — | CN | disclosed |
| EP-2968546-B1 | METHODS OF GENERATING BIOACTIVE PEPTIDE-BEARING ANTIBODIES AND COMPOSITIONS COMPRISING THE SAME | OMEROS CORP (US) | 2023-09-20 | — | — | EP | disclosed |
| US-20230272035-A1 | MODULATORS OF THE IMMUNE ESCAPE MECHANISM FOR UNIVERSAL CELL THERAPY | VYCELLIX, INC. (US) | 2023-08-31 | — | — | US | disclosed |
| EP-4069748-A1 | MODULATORS OF THE IMMUNE ESCAPE MECHANISM FOR UNIVERSAL CELL THERAPY | Vycellix, Inc. (US) | 2022-10-12 | — | — | EP | disclosed |
| WO-2022186782-A1 | METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Nγ-HYDROXY- OR Nγ-AMINO-L-ASPARAGINE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-09-09 | — | — | WO | disclosed |
| EP-3698832-B1 | METHODS AND DEVICES FOR SMOKING URGE RELIEF | FONTEM HOLDINGS 1 BV (NL) | 2022-07-13 | — | — | EP | disclosed |
| US-20220213461-A1 | ASX-SPECIFIC PROTEIN LIGASES AND USES THEREOF | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-07-07 | — | — | US | disclosed |
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | disclosed |
| CN-106459160-B | ASX-specific protein ligases | 南洋理工大学 | 2022-03-29 | — | — | CN | disclosed |
| EP-3966321-A1 | ASX-SPECIFIC PROTEIN LIGASES AND USES THEREOF | Nanyang Technological University (SG) | 2022-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | CALCR 118/4885NTSR1 18/4885CRHR1 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.